SS Innovations International

SSII

Valor de mercado US$ 507 mi

FORT LAUDERDALE, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that, on October 5, 2026, the Company submitted its response to a request for additional information letter (the “AINN”) received from the United States Food and Drug Administration (the “FDA”) with regard to the Company's 510(k) submission for its SSi Mantra surgical robotic system (the “SSi Mantra”).

SSII and IVDA have sales predominantly in India and Taiwan, respectively.

Discover why Zacks initiated coverage of SSII with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how expanding robotic surgery adoption, rising revenues and international growth are offset by persistent losses and regulatory hurdles.

-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided an update on the Company's continuing progress and milestones.

Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales

Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event

Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth

AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- via  IBN – SS Innovations International, Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, has engaged IBN , a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.

New course empowers healthcare professionals through expert instruction and hands-on learning New course empowers healthcare professionals through expert instruction and hands-on learning

Company celebrated for advancing global access to its innovative robotic surgery platform Company celebrated for advancing global access to its innovative robotic surgery platform